Novartis commenced 2026 with two significant recognitions in Saudi Arabia, affirming its leadership in clinical research and contributions to the Kingdom’s developing healthcare sector. At the Clinical Trials Transformation Conference: Unraveling the Future in Riyadh, Novartis was awarded First
